Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction

Metabolic Brain Disease

Volumn 26, Issue 4, 2011, Pages 253-267

  Ghareeb, Doaa A ^a   Hafez, Hani S ^b   Hussien, Hend M ^c   Kabapy, Nihal F ^d  

^a Alexandria University Faculty Of Science   (Egypt)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

^c Pharos University of Alexandria   (Egypt)

^d Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

AChE; Brain dysfunction; Insulin resistance; MAO; NAFLD

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE; AMINE OXIDASE (FLAVIN CONTAINING); ANTIOXIDANT; BRAIN ENZYME; CARBON TETRACHLORIDE; CYTOCHROME P450 2E1; CYTOKINE; GLUCOSE; INTERLEUKIN 6; LIVER ENZYME; NEUROTRANSMITTER; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN DYSFUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY YIELD; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BRAIN LEVEL; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; METABOLIC DISORDER; NERVE DEGENERATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; RAT; RISK FACTOR; SPECTROPHOTOMETRY;

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD GLUCOSE; BRAIN; BRAIN CHEMISTRY; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MONOAMINE OXIDASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 83655201397     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-011-9261-y     Document Type: Article

References (94)

1. S Ahboucha R Butterworth 2008 The neurosteriod system: implication in the pathophysiology of hepatic eccephalopathy Neurochem Int 52 575 585 17610999 10.1016/j.neuint.2007.05.004 1:CAS:528:DC%2BD1cXhsVKhurg%3D
2. S Aleynik M Leo M Aleynik C Leiber 1997 Polyenyphosphatidylcholine prevents carbon tetrachloride induced lipid peroxidation while it attenuates liver fibrosis J Hepatol 27 554 556 9314134 10.1016/S0168-8278(97)80361-3 1:CAS:528:DyaK2sXmsVamtbs%3D (Pubitemid 27390904)
3. FA Anania S Parekh 2007 Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease Gastroenterology 132 2191 2207 17498512 10.1053/j.gastro.2007.03.055 (Pubitemid 46693752)
4. N Angelini A Rafacho AC Boschero JR Bosqueiro 2010 Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats Diabetes Res Clin Pract 87 184 191 19962776 10.1016/j.diabres.2009.11.008 1:CAS:528:DC%2BC3cXhtVGgu7w%3D
5. P Angulo 2007 GI epidemiology: nonalcoholic fatty liver disease: incidence and prevalence Aliment Pharmacol Ther 25 8 883 889 17402991 10.1111/j.1365-2036.2007.03246.x 1:STN:280:DC%2BD2s3gtVyrtA%3D%3D
6. WA Banks 2004 The source of cerebral insulin Eur J Pharmacol 490 5 12 15094069 10.1016/j.ejphar.2004.02.040 1:CAS:528:DC%2BD2cXjt1ShsLs%3D (Pubitemid 38482157)
7. VG Bardov GM Shmuter BP Suchkov GA Stepanenko IV Khalavchuk SK Gerashchenko VA Kapelist 1990 The effect of a complex of preventive agents on the level of radioactive cesium and strontium in the bodies of laboratory animals (white rats) Gig Sanit 10 51 52 2074028
8. GD Baura DM Foster K Kaiyala D Porte E Kahn W Schwartz 1996 Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs Diabetes 45 1 86 90 8522065 10.2337/diabetes.45.1.86 1:CAS:528:DyaK28XhvFarsg%3D%3D (Pubitemid 26010428)
9. M Beal 2005 Mitochondria take centre stage in aging and neurodegeneration Ann Neurol 58 495 505 16178023 10.1002/ana.20624 1:CAS:528:DC%2BD2MXhtFGrs7fE (Pubitemid 41377212)
10. GJ Biessels LJ Kappalle 2005 Uhrecht Diabetic Encephalopathy Study Group: Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33 1041 1044 16246041 10.1042/BST20051041 1:CAS:528:DC%2BD2MXhtFCqs7jO (Pubitemid 41659109)
11. E Bingham D Hopkins D Smith A Pernet W Hallett L Reed 2002 The role of insulin in human brain glucose metabolism: an fluoro-deoxyglucose positron emission tomography study Diabetes 51 12 3384 3390 12453890 10.2337/diabetes.51. 12.3384 1:CAS:528:DC%2BD38Xptl2ntbg%3D (Pubitemid 35403440)
12. F Bosetti F Brizzi S Barogia M Mancuso G Siciliano E Tendi L Murric S Rapoport G Solaini 2002 Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease Neurobiol Aging 23 371 376 11959398 10.1016/S0197-4580(01)00314-1 1:CAS:528:DC%2BD38XivVShu7c%3D (Pubitemid 34312019)
13. JD Browning JD Horton 2004 Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 147 152 15254578 1:CAS:528:DC%2BD2cXlvFWms7c%3D (Pubitemid 39071617)
14. D Cai M Yuan DF Frantz, et al. 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 183 190 15685173 10.1038/nm1166 1:CAS:528:DC%2BD2MXpvF2ntQ%3D%3D (Pubitemid 40321354)
15. V Calabrese G Scapagnini A Giuffrida-Stella T Bates J Clark 2001 Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity Neurochem Res 26 739 764 11519733 10.1023/A:1010955807739 1:CAS:528:DC%2BD3MXmtFKrtLY%3D (Pubitemid 32756837)
16. F Candeiasa P Abreub A Pereiraa J Cruz-Morais 2009 Effects of strictosamide on mouse brain and kidney Na+, K+-ATPase and Mg2+-ATPase activities J Ethnopharmacology 121 117 122 10.1016/j.jep.2008.08.032
17. Q Cao KM Mak CS Lieber 2005 Cytochrome P4502E1 primes macrophages to increase TNF- production in response to lipopolysaccharide Am J Physiol Gastrointest Liver Physiol 289 G95 G107 15961886 10.1152/ajpgi.00383.2004 1:CAS:528:DC%2BD2MXmvVeqsrk%3D (Pubitemid 40944228)
18. A Caro L Evans I Cederbaum 2009 CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells Toxicology 255 171 176 19028543 10.1016/j.tox.2008.10.020 1:CAS:528:DC%2BD1MXksVWjtw%3D%3D
19. JA Chavez SA Summers 2003 Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes Arch Biochem Biophys 419 101 109 14592453 10.1016/j.abb.2003.08.020 1:CAS:528:DC%2BD3sXosVyhurc%3D (Pubitemid 37329976)
20. P Choudhary V Malik S Puri P Ahluwalia 1996 Studies on the effects of monosodium glutamate on hepatic microsomal lipid peroxidation, calcium, ascorbic acid and glutathione and its dependent enzymes in adult male mice Toxicol Lett 89 71 76 8952714 10.1016/S0378-4274(96)03786-1 1:CAS:528:DyaK28XmvFeltbo%3D (Pubitemid 26396535)
21. L Cibickova R Hyspler S Micuda N Cibicek D Jun A Ticha E Brcakova V Palicka H Zivna 2009 The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain Steroids 74 13 19 18817797 10.1016/j.steroids.2008.08.007 1:CAS:528:DC%2BD1cXhsV2gsLzO
22. S Craft 2005 Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation Neurobiol Aging 26 65 69 16266773 10.1016/j.neurobiolaging.2005.08.021 (Pubitemid 41739429)
23. S Craft G Watson 2004 Insulin and neurodegenerative disease: shared and specific mechanisms Lancet Neurol 3 3 169 178 14980532 10.1016/S1474-4422(04) 00681-7 1:CAS:528:DC%2BD2cXjtVCqtLg%3D (Pubitemid 38229951)
24. S Craft S Asthana JW Newcomer CW Wilkinson IT Matos LD Baker, et al. 1999 Enhancement of memory in Alzheimer's disease with insulin and somatostatin, but not glucose Arch Gen Psychiatry 56 1135 1140 10591291 10.1001/archpsyc.56.12. 1135 1:CAS:528:DC%2BD3cXls1Ortg%3D%3D
25. CP Day OF James 1998 Steatohepatitis: a tale of two "hits"? Gastroenterology 114 842 845 9547102 10.1016/S0016-5085(98)70599-2 1:STN:280:DyaK1c3htFartQ%3D%3D (Pubitemid 28160420)
26. DA De Luis R Aller O Izaola, et al. 2008 Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance Diabetes Res Clin Pract 79 74 78 17766001 10.1016/j.diabres.2007.07.015
27. AM Diehl 2002 Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines Am J Physiol Gastrointest Liver Physiol 282 G1 G5 11751151 1:CAS:528: DC%2BD38XlsVKrug%3D%3D
28. H Drake H Goss G Wood 1979 New convenient method for the rapid analysis of inorganic pyrophosphate Anal Biochem 94 117 120 223468 10.1016/0003-2697(79) 90800-5 1:CAS:528:DyaE1MXhsVOqurw%3D (Pubitemid 9170213)
29. RH Eckel SM Grundy PZ Zimmet 2005 The metabolic syndrome Lancet 365 1415 1428 15836891 10.1016/S0140-6736(05)66378-7 1:CAS:528:DC%2BD2MXjsVegtbg%3D (Pubitemid 40523737)
30. G Ellman K Courtney V Andres R Featherstone 1961 A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 88 95 13726518 10.1016/0006-2952(61)90145-9 1:CAS:528:DyaF3MXht1Gns7o%3D
31. MG Emery JM Fisher JY Chien, et al. 2003 CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease Hepatology 38 428 435 12883487 10.1053/jhep.2003.50342 1:CAS:528: DC%2BD3sXmvFSmurw%3D (Pubitemid 36919864)
32. GC Farrell CZ Larter 2006 Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 S99 S112 16447287 10.1002/hep.20973 1:CAS:528:DC%2BD28XhvVSktLo%3D
33. P Fossati L Prencipe 1982 Triglyceride determination calorimetrically with an enzyme that produces hydrogen peroxide Clin Chem 28 2077 2080 6812986 1:CAS:528:DyaL38XlvFGhtrk%3D (Pubitemid 12034053)
34. J Fowler N Volkow G Wang N Pappas J Logan R Mac Gregor D Alexoff A Wolf D Warner R Cilento I Zezulkova 1998 Neuropharmacological action of cigarette smoke: brain monoamine oxidase B (MAOB) inhibition J Addict Dis 17 23 34 9549600 10.1300/J069v17n01-03 1:STN:280:DyaK1c3htVOluw%3D%3D (Pubitemid 28156155)
35. D Ghareeb H Hussein 2008 Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats Neurosci Lett 436 44 47 18378083 10.1016/j.neulet.2008.02.073 1:CAS:528:DC%2BD1cXks1art78%3D
36. D Ghareeb H Hussein A Khalil M El-Saadani A Ali 2010 Toxic effects of lead exposure on the brain of rats: Involvement of oxidative stress, inflammation, acetylcholinesterase, and the beneficial role of flaxseed extract Toxicol Environ Chem 92 1 187 195 10.1080/02772240902830631 1:CAS:528: DC%2BC3cXhslWrsg%3D%3D
37. Ghareeb D, Khalil A, Elbassoumy A, Hussien H, Abo-Sraiaa M (2010b) Ameliorated effects of garlic (Allium sativum) on biomarkers of subchronic acrylamide hepatotoxicity and brain toxicity in rats. Toxicol Environ Chem 92(7):1357-1372
38. Halliwell B, Gutteridge J (2000) Free radicals in biology and medicine. In: (ed) Oxford University Press, pp 148-149
39. M Hare 1928 Tyramine oxidase. I. A new enzyme system in liver Biochem J 22 4 968 979 16744124 1:CAS:528:DyaB1MXptlc%3D
40. N Hattori K Kitagawa K Higashida K Yagyu S Shimoham T Watay G Perry M Smith C Inagaki 1998 Cl-ATPase and Na/K-ATPase activities in Alzheimer's disease brains Neurosci Lett 254 141 144 10214977 10.1016/S0304-3940(98)00654-5 1:CAS:528:DyaK1cXms1Squ7c%3D (Pubitemid 28459401)
41. M Hjelm C De Verdier 1963 Determination of serum glucose by glucose oxidase method Scand J Clin Lab Invest 15 415 428 14073292 10.3109/ 00365516309079764 1:CAS:528:DyaF2cXjt1Oksw%3D%3D
42. C Hsu L Guo 2002 Antioxidant nutrients and lead toxicity Toxicology 180 1 33 44 12324198 10.1016/S0300-483X(02)00380-3 1:CAS:528:DC%2BD38Xnt1Gjtb8%3D (Pubitemid 35248091)
43. W Hu NW Gray S Brimijoin 2003 Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation J Neurochem 86 470 478 12871588 10.1046/j.1471-4159.2003.01855.x 1:CAS:528: DC%2BD3sXlslGht7w%3D (Pubitemid 36842446)
44. S Hummel A Fischer S Martin F Schafer G Buettner 2006 Nitric oxide as a cellular antioxidant: a little goes a long way Free Radic Biol Med 40 501 506 16443165 10.1016/j.freeradbiomed.2005.08.047 1:CAS:528:DC%2BD28XovVSgtA%3D%3D (Pubitemid 43139685)
45. JH Hwang DT Stein N Barzilai MH Cui J Tonelli P Kishore M Hawkins 2007 Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies Am J Physiol Endocrinol Metab 293 E1663 E1669 17911339 10.1152/ajpendo.00590.2006 1:CAS:528: DC%2BD2sXhsVGls7vJ (Pubitemid 350255117)
46. Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. Commission on life sciences, national research council. National Academy, Washington, DC
47. M Johansen L Bak A Schousboe P Iversen S Keiding M Sorensen H Vilstrup A Gjedde P Ott H Waagepetersen 2007 The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes Neurochem Int 50 1042 1051 17346854 10.1016/j.neuint.2007.01.009 1:CAS:528: DC%2BD2sXmvVKms70%3D (Pubitemid 46962815)
48. D Jollow J Mitchell N Zampaglione J Gillette 1974 Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzenoxide as the hepatotoxic intermediate Pharmacology 11 151 169 4831804 10.1159/000136485 1:CAS:528:DyaE2cXkslejtLk%3D
49. KM Korenblat E Fabbrini BS Mohammed S Klein 2008 Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 1369 1375 18355813 10.1053/j.gastro.2008.01.075 1:CAS:528:DC%2BD1cXntVWhtbo%3D (Pubitemid 351615354)
50. H Lam C Yeh K Cheng C Hus J Cheng 2008 Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats Neuroscience Lett 438 90 95 10.1016/j.neulet.2008.04.048 1:CAS:528:DC%2BD1cXmtlSrtLc%3D
51. G Litwack JW Bothwell JN Williams J Elvehjem 1953 A colorimetric assay for xanthine oxidase in rat liver homogenates J Biol Chem 200 303 310 13034787 1:CAS:528:DyaG3sXit1Gitw%3D%3D
52. GA Macdonald KR Bridle PJ Ward, et al. 2001 Lipid peroxidation in hepatic steatosis is associated with hepatic fibrosis and occurs predominantly in acinar zone 3 J Gastroenterol Hepatol 16 599 606 11422610 10.1046/j.1440-1746. 2001.02445.x 1:CAS:528:DC%2BD3MXlslSlsLY%3D (Pubitemid 34188832)
53. G Marchesini E Bugianesi G Forlani F Cerrelli M Lenzi R Manini S Natale E Vanni N Villanova N Melchionda M Rizzetto 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 917 923 12668987 10.1053/jhep.2003.50161 (Pubitemid 36397405)
54. AJ McCullough 2004 The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease Clin Liver Dis 8 VIII521 VIII533 10.1016/j.cld.2004.04.004 (Pubitemid 39141140)
55. JD McGarry 2002 Dys-regulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 51 7 18 11756317 10.2337/diabetes.51.1.7 1:CAS:528:DC%2BD38Xlt1ejsQ%3D%3D
56. JD McGarry RL Dobbins 1999 Fatty acids, lipotoxicity and insulin secretion Diabetologia 42 128 138 10064091 10.1007/s001250051130 1:CAS:528:DyaK1MXhtFajsbg%3D (Pubitemid 29064233)
57. JH Meyer N Ginovart A Boovariwala S Sagrati D Hussey A Garcia T Young N Praschak-Rieder AA Wilson S Houle 2006 Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression Arch Gen Psychiatry 63 11 1209 1216 17088501 10.1001/archpsyc.63.11.1209 1:CAS:528:DC%2BD28XhtlSksL%2FJ (Pubitemid 44708079)
58. H Montgomery J Dymock 1961 The determination of nitrite in water Analyst 35 414 416
59. G Musso R Gambino M Cassader 2009 Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) Prog Lipid Res 48 1 26 18824034 10.1016/j.plipres.2008.08.001 1:CAS:528:DC%2BD1cXhsFagu7%2FO
60. BA Neuschwander-Tetri EM Brunt KR Wehmeier, et al. 2003 Interim results of a pilot study demonstrating the early effects of the PPAR-g ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis J Hepatol 38 434 440 12663234 10.1016/S0168-8278(03)00027-8 1:CAS:528:DC%2BD3sXit1yqu7s%3D (Pubitemid 36399245)
61. A Ott RP Stolk A Hofman F van Harskamp DE Grobbee MM Breteler 1999 Association of diabetes mellitus and dementia: The Rotterdam study Diabetologia 39 1392 1397 10.1007/s001250050588
62. E Paglia N Valentine 1967 Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 158 169 6066618 1:CAS:528:DyaF2sXks1Wjur8%3D
63. M Perez-Carreras P Del Hoyo MA Martin, et al. 2003 Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis Hepatology 38 999 1007 14512887 1:CAS:528:DC%2BD3sXovFGhurY%3D (Pubitemid 37221683)
64. D Pessayre A Mansouri B Fromenty 2002 Nonalcoholic steatosis and steatohepatitis: mitochondrial dysfunction in steatohepatitis Am J Physiol Gastrointest Liver Physiol 282 G193 G199 11804839 1:CAS:528:DC%2BD38XhtFGitbk%3D
65. KF Petersen S Dufour D Befroy M Lehrke RE Hendler GI Shulman 2005 Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes Diabetes 54 603 608 15734833 10.2337/diabetes.54.3.603 1:CAS:528: DC%2BD2MXitlehu7s%3D (Pubitemid 40322060)
66. P Plomgaard K Bouzakri R Krogh-Madsen, et al. 2005 Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 54 2939 2945 16186396 10.2337/diabetes.54.10.2939 1:CAS:528:DC%2BD2MXhtV2rs7%2FJ (Pubitemid 41401090)
67. Plummer D (1978) Amino acids and proteins. In: (ed) An introduction to practical biochemistry. UK, McGraw- Hill Book Co, pp 145-146
68. JK Reddy 2001 Nonalcoholic steatosis and steatohepatitis: peroxisomal β-oxidation, PPAR-α and steatohepatitis Am J Physiol Gastrointest Liver Physiol 281 G1333 G1339 11705737 1:CAS:528:DC%2BD3MXptlKmtLw%3D
69. MA Reger GS Watson PS Green CW Wilkinson LD Baker B Cholerton, et al. 2008 Intranasal insulin improves cognition and modulates β-amyloid in early AD Neurology 70 6 440 448 17942819 10.1212/01.WNL.0000265401.62434.36 1:CAS:528:DC%2BD1cXhtFels70%3D
70. GR Robertson I Leclercq GC Farrell 2001 Nonalcoholic steatosis and steatohepatitis: cytochrome P-450 enzymes and oxidative stress Am J Physiol Gastrointest Liver Physiol 281 G1135 G1139 11668021 1:CAS:528: DC%2BD3MXos1ags7w%3D
71. M Robin I Sauvage T Grandperret V Descatoire D Pessayre B Fromenty 2005 Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes FESB Lett 579 6895 6902 10.1016/j.febslet.2005.11.029 1:CAS:528:DC%2BD2MXht12qurrI (Pubitemid 41773706)
72. L Rojo MK Sjöberg P Hernández C Zambrano RB Maccioni 2006 Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease J Biomed Biotechnol 3 73 90
73. VT Samuel ZX Liu X Qu BD Elder S Bilz D Befroy AJ Romanelli GI Shulman 2004 Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease J Biol Chem 279 32345 32353 15166226 10.1074/jbc.M313478200 1:CAS:528:DC%2BD2cXmtVChsL0%3D (Pubitemid 39014687)
74. VT Samuel ZX Liu A Wang SA Beddow JG Geisler M Kahn XM Zhang BP Monia S Bhanot GI Shulman 2007 Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease J Clin Invest 117 739 745 17318260 10.1172/JCI30400 1:CAS:528:DC%2BD2sXis12htLo%3D (Pubitemid 46348532)
75. M Sandler M Reveley V Glover 1981 Human platelet monoamine oxidase activity in health and disease: a review J Clin Pathol 34 292 302 6453137 10.1136/jcp.34.3.292 1:CAS:528:DyaL3MXhvV2ltb8%3D (Pubitemid 11153594)
76. AJ Sanyal C Campbell-Sargent F Mirshahi, et al. 2001 Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 1183 1192 11266382 10.1053/gast.2001.23256 1:CAS:528:DC%2BD3MXjtVeqsb8%3D (Pubitemid 32246672)
77. JJ Schildkraut JM Herzog PJ Orsulak SE Edelman HM Shein SHSH Frazier 1976 Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients Am J Psychiatry 133 4 438 440 1267046 1:STN:280:DyaE287ot1WmtQ%3D%3D
78. S Seki T Kitada T Yamada H Sakagushi K Nakatani K Wakasa 2002 In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases J Hepatol 37 56 62 12076862 10.1016/S0168-8278(02)00073-9 1:CAS:528:DC%2BD38XksFymu7s%3D (Pubitemid 34713055)
79. G Serviddio J Sastre F Bellanti J Vina G Vendemiale E Altomare 2008 Mitochondrial involvement in non-alcoholic steatohepatitis Mol Aspects Med 29 22 35 18061659 10.1016/j.mam.2007.09.014 1:CAS:528:DC%2BD1cXivVyntbo%3D (Pubitemid 351312221)
80. SE Shoelson J Lee AB Goldfine 2006 Inflammation and insulin resistance J Clin Invest 116 1793 1801 16823477 10.1172/JCI29069 1:CAS:528: DC%2BD28XmvV2ltLo%3D
81. Srivastava L, Das N, Sinha S (2002) Quantitative estimation of analytes in blood. In: Srivastava L, Das N, Sinha S (eds) Essential of practical biochemistry. CBS publishers and distributors, New Delhi, pp 91-94
82. K Tokushige M Takakura N Tsuchiya-Matsushita, et al. 2007 Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis J Hepatol 46 1104 1110 17395331 10.1016/j.jhep.2007.01.028 1:CAS:528: DC%2BD2sXkvFGjsbk%3D (Pubitemid 46669735)
83. L Valenti AL Fracanzani P Dongiovanni, et al. 2002 Tumor necrosis factor-alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 274 280 11832442 10.1053/gast.2002.31065 1:CAS:528:DC%2BD38XhsVGnsrk%3D (Pubitemid 34116980)
84. LA Videla R Rodrigo M Orellana, et al. 2004 Oxidative stress-related parameters in the liver of nonalcoholic fatty liver disease patients Clin Sci 106 261 268 14556645 10.1042/CS20030285 1:CAS:528:DC%2BD2cXisVyrtL8%3D (Pubitemid 38365832)
85. C Vives-Bauza R Gonzalo G Manfredi E Garcia-Arumi A Andreu 2006 Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA Neurosci Lett 391 136 141 16165271 10.1016/j.neulet.2005.08.049 1:CAS:528:DC%2BD2MXht1OksrjK (Pubitemid 41736187)
86. D Watson 1960 A simple method for the determination of serum cholesterol Clinica Chemica Acta 5 637 643 10.1016/0009-8981(60)90004-8 1:CAS:528: DyaF3MXos1am
87. GS Watson S Craft 2006 Insulin resistance, inflammation, and cognition in Alzheimer's Disease:Lessons for multiple sclerosis J Neurol Sci 245 21 33 16631207 10.1016/j.jns.2005.08.017 1:CAS:528:DC%2BD28Xlt1CltL0%3D
88. L Weber M Boll A Stampfl 2003 Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model Crit Rev Toxicol 33 105 136 12708612 10.1080/713611034 1:CAS:528:DC%2BD3sXjtlOgtbw%3D (Pubitemid 36432872)
89. MD Weltman GC Farrell P Hall M Ingelman-Sundberg C Liddle 1998 Hepatic cytochrome P450 2E1 is increased in patients with non alcoholic steatohepatitis Hepatology 28 128 133 10.1002/hep.510270121 (Pubitemid 28041545)
90. ED Wills 1965 Mechanisms of lipid peroxide formation in animal tissues Biochem J 99 3 667 676
91. C Yu F Wang C Jin X Wu W Chan W McKeehan 2002 Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice Am J Pathol 161 2003 2010 12466116 10.1016/S0002-9440(10)64478-1 1:CAS:528: DC%2BD38Xpslemtbk%3D (Pubitemid 35434846)
92. WQ Zhao DL Alkon 2001 Role of insulin and insulin receptor in learning and memory Mol Cell Endocrinol 177 1-2 125 134 11377828 10.1016/S0303-7207(01) 00455-5 1:CAS:528:DC%2BD3MXjslSktLc%3D (Pubitemid 32506813)
93. S Zheng GL Newton G Gonick RC Fahey JF Ward 1988 Radioprotection of DNA by thiols: relationship between the net charge on a thiol and its ability to protect DNA Radiat Res 114 11 27 3127858 10.2307/3577140 1:CAS:528: DyaL1cXitVSqsrk%3D
94. N Zollner K Kirsch 1962 Absorptimetric determination of total lipids in serum Z Ges Exp Med 135 544 549 10.1007/BF02045455